What does this research mean for the field?

Progression of frailty status increases the risk of almost all new-onset chronic diseases, whereas recovery from frailty reduces the incidence of multiple conditions including cardiovascular disease, stroke, and memory disease. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To investigate how longitudinal changes in frailty status relate to the subsequent incidence of new-onset chronic diseases among middle-aged and older adults.

December 15, 2025BMC Public HealthOpen Access

Associations of changes in frailty with multiple chronic diseases in middle aged and elderly adults

Q: What is the clinical evidence from this study?

Study design: Cohort. Population: Frailty and chronic diseases (n=7021). Intervention: Progression or recovery of frailty status vs. Stable frailty status (stable robust, pre-frail, or frail). Primary outcome: Incidence of new-onset chronic diseases (HR 1.38-2.73).

View Full Paper

Ask AI

Bookmark

Key result

Frailty progression is linked to up to ~173% higher risk of incident chronic diseases.

Why the study?

Evidence on the associations between changes in frailty status and the incidence of new-onset chronic diseases remains limited.

Does a change in frailty status affect the risk of new-onset chronic diseases in middle-aged and elderly adults?

Key Points

To investigate how longitudinal changes in frailty status relate to the subsequent incidence of new-onset chronic diseases among middle-aged and older adults.
Retrospective analysis of prospectively collected data from the China Health and Retirement Longitudinal Study (CHARLS) involving 7,021 adults aged 45 years or older.
Frailty was measured via the Rockwood frailty index at baseline (2011) and a two-year follow-up (2013), categorizing participants as robust, pre-frail, or frail.
Cox proportional hazards regression models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for incident chronic diseases identified by self-reported physician diagnoses.
Robust participants who progressed to pre-frail or frail status exhibited increased risks for nearly all evaluated chronic diseases (HRs: 1.38–2.73), except cancer (HR: 1.32; 95% CI: 0.83–2.12).
Pre-frail participants who progressed to frail status showed heightened risks specifically for hypertension (HR: 1.34; 95% CI: 1.01–1.77) and memory disease (HR: 1.63; 95% CI: 1.11–2.39).
Recovery to robust status among pre-frail adults reduced risks of cardiovascular disease, heart disease, stroke, kidney disease, digestive disease, psychiatric disease, and memory disease (HRs: 0.39–0.66), with similar risk reductions observed in frail participants who recovered (HRs: 0.39–0.73).

Study Design

Type

Cohort (n=7,021)

Multicenter

Yes

Structured PICO

Does a change in frailty status affect the risk of new-onset chronic diseases in middle-aged and elderly adults?

Population

7,021 adults aged 45 years and older from China, followed to assess how changes in frailty status affect the incidence of 14 new-onset chronic diseases.

Exposure

Progression or recovery of frailty status (assessed by Rockwood frailty index) between baseline (2011) and second survey (2013)

Comparator

Stable frailty status (stable robust, stable pre-frail, or stable frail)

Outcome

Incidence of new-onset chronic diseases (14 chronic diseases including CVD, heart disease, stroke, hypertension, diabetes, cancer, etc.) identified by self-reported physician diagnosis

Main Result

Effect estimate: HR 1.38-2.73

Limitations

Reliance on self-reported data for the assessment of chronic diseases, which may be subject to misclassification bias.
Optimal frailty index thresholds for defining frailty status remain unclear.
Exclusion of 10,687 participants may have introduced selection bias (healthy participant bias).
Conducted in a Chinese cohort, so generalizability to other ethnic groups needs further confirmation.
Potential for residual confounding due to the observational study design.

Implication

Frailty transitions were associated with varying chronic disease risks; leaves open whether targeting frailty changes improves outcomes.

Abstract

BACKGROUND: Although the impact of baseline frailty status on chronic disease risks has been well-established, evidence on the associations between changes in frailty status and the incidence of new-onset chronic diseases remains limited. METHODS: A retrospective study of prospectively collected data from the China Health and Retirement Longitudinal Study (CHARLS) including 7 021 adults aged 45 years or older. Frailty status was evaluated by the Rockwood frailty index and classified as robust, pre-frail, or frail. Changes in frailty status were assessed by frailty status at baseline (2011) and the second survey (2013). All chronic diseases were identified by self-reported physician diagnosis. Cox proportional hazards regression models were used to estimate hazard ratios (HRs) and 95% CIs. RESULTS: Compared to stable robust participants, robust participants who progressed to pre-frail/frail status had significantly elevated risks of all chronic diseases studied (HRs: 1.38-2.73), except for cancer (HR: 1.32; 95% CI: 0.83-2.12). Pre-frail participants who progressed to frail status showed only significantly elevated risks of hypertension (HR: 1.34; 95% CI: 1.01-1.77) and memory disease (HR: 1.63; 95% CI: 1.11-2.39) compared to stable pre-frail participants. In contrast, pre-frail participants who recovered to robust status demonstrated decreased risks of CVD, heart disease, stroke, kidney disease, digestive disease, psychiatric disease, and memory disease than stable pre-frail participants (HRs: 0.39-0.66). Similarly, frail participants who recovered to robust/pre-frail status also showed decreased risks of CVD, stroke, diabetes, psychiatric disease, and memory disease compared to stable frail participants (HRs: 0.39-0.73). CONCLUSIONS: Different changes in frailty status are associated with different risks of new-onset chronic diseases. Progression of frailty status increases risks of almost all chronic diseases, while recovery of frailty status decreases risks of approximately half of all chronic diseases.

Discussion

No takes yet. Share an insight, caveat, or question.

Figures from the paper

Published by BMC Public Health · CC BY-NC-ND

Cite This Study

Yao et al. (2025) conducted a cohort in Frailty and chronic diseases (n=7,021). Progression or recovery of frailty status vs. Stable frailty status (stable robust, pre-frail, or frail) was evaluated on Incidence of new-onset chronic diseases (HR 1.38-2.73). Progression from robust to pre-frail or frail status significantly increased the risks of almost all studied chronic diseases (HRs 1.38-2.73), whereas recovery from frailty decreased the risks.

synapsesocial.com/papers/6a9436069fbe5f86ceb9620d https://doi.org/10.1186/s12889-025-25872-6

View Full Paper

Ask AI

Bookmark

Implication

Frailty transitions were associated with varying chronic disease risks; leaves open whether targeting frailty changes improves outcomes.

Associations of changes in frailty with multiple chronic diseases in middle aged and elderly adults

Key Points

Study Design

Structured PICO

Main Result

Limitations

Implication

Abstract

Discussion

Figures from the paper

Cite This Study

Associations of changes in frailty with multiple chronic diseases in middle aged and elderly adults

Key Points

Study Design

Structured PICO

Main Result

Limitations

Implication

Abstract

Discussion

Figures from the paper

Cite This Study

Keep reading

Keep reading